Catalyst Wire Dossier Catalyst Wire Dossier

ST-100 (Vezocolmitide)

Vezocolmitide · ORA, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ST-100 (Vezocolmitide), covering 2024-01-18 to 2024-01-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED) [Phase 3]

See pricing